Vimarsana
Biggest News Aggregation in the World

Study Director News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Director. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Director Today - Breaking & Trending Today

Space Force reexamining acquisition strategy for secure narrow-band communications - Vimarsana News

Space Force reexamining acquisition strategy for secure narrow-band communications

On Jan. 25, DoD announced that Lockheed Martin and Boeing have each won 15-month contracts worth $66 million to develop a new, more modern satellite design, with the service then deciding on which to use in building the two new MUOS birds. 

Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like - Vimarsana News

Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like

LAVAL, Québec--(BUSINESS WIRE)--#Altasciences--Altasciences is pleased to have been chosen by Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) (“Virpax”), a company specializing in developing non-addictive products for pain management, PTSD, central nervous system (CNS) disorders, and viral barrier indications, to conduct...

HPAPIs: Risks, regulations, and revolutionary applications - Vimarsana News

HPAPIs: Risks, regulations, and revolutionary applications

In the rapidly evolving world of pharmaceutical development, high-potency active pharmaceutical ingredients (HPAPIs) are becoming powerful tools.

Mouse models for translational pharmacokinetic data - Vimarsana News

Mouse models for translational pharmacokinetic data

Explore human FcRn mouse models that provide accurate preclinical assessment to give translational pharmacokinetic data

Latina Research Leader returns to The Hispanic Association on Corporate Responsibility - Vimarsana News

Latina Research Leader returns to The Hispanic Association on Corporate Responsibility

Dr. Lisette M. Garcia is coming back to the organization as Chief Research Officer.